NCT07905911
Maximum Lysis on Thromboelastography as a Marker of Systemic Severity in Acute Allergic Reactions
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Maximum Lysis by Allergic Reaction Severity
Timeframe: Baseline
Secondary (2)
Hospital Admission
Intensive Care Utilization
Arms and interventions
Diagnostic tests: Thromboelastogram
Sites
1 site in 1 country
- Mayo ClinicRochester, Minnesota, United States